Modeling Corticosteroid Pharmacogenomics and Proteomics in Rat Liver

Area of Science:

• Pharmacogenomics and proteomics
• Molecular biology
• Systems biology

Background:

• Corticosteroids (CS) are potent regulators of gene expression at both mRNA and protein levels.
• Understanding the temporal dynamics of CS pharmacogenomics and proteomics is crucial for elucidating their mechanisms of action.

Purpose of the Study:

• To quantitatively analyze the time course of CS-regulated gene expression at both mRNA and protein levels in rat liver.
• To develop and apply mathematical models to describe CS-induced changes in gene expression dynamics.

Main Methods:

• Adrenalectomized rats were administered methylprednisolone.
• Hepatic transcriptomics (microarrays) and proteomics (mass spectrometry) were used to quantify gene and protein dynamics.
• Mathematical modeling was employed to describe temporal expression patterns.

Main Results:

• 163 differentially expressed genes and their proteins were identified and clustered.
• Protein expression kinetics were generally delayed compared to mRNA, attributed to synthesis and degradation.
• Mathematical models successfully described various expression patterns, including stimulation, inhibition, and complex dynamics.

Conclusions:

• CS-regulated gene expression involves intricate mechanisms affecting mRNA and protein turnover.
• Quantitative models integrating mRNA and protein data provide insights into CS's direct, secondary, and downstream effects.
• The study expands understanding of CS pharmacogenomics from mRNA to protein levels.